Syndax Pharmaceuticals, Inc. (SNDX)

NASDAQ: SNDX · Real-Time Price · USD

20.37

-0.03 (-0.15%)

At close: Aug 10, 2026, 4:00 PM EDT

20.30

-0.07 (-0.34%)

After-hours: Aug 10, 2026, 7:34 PM EDT

Syndax Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	252.25	172.35	23.68	-	-	139.71
Revenue Growth	222.65%	627.84%	-	-	-	9109.56%
Cost of Revenue	10.65	6.97	0.83	-	-	-
Gross Profit	241.6	165.38	22.85	-	-	139.71
Selling, General & Admin	173.97	179.68	120.88	66.92	33.26	25.24
Research & Development	261.8	258.78	241.65	163.03	118.5	88.25
Total Operating Expenses	435.78	438.47	362.53	229.95	151.76	113.49
Operating Income	-194.17	-273.08	-339.67	-229.95	-151.76	26.22
Interest Income	25.19	22.73	26.09	21.16	5.87	0.4
Interest Expense	-0.56	-33.78	-4.93	-	-3.14	-1.9
Other Non-Operating Income (Expense)	-0.9	-13.63	20.67	20.03	-0.32	0.2
Total Non-Operating Income (Expense)	23.74	-24.68	41.83	41.19	2.42	-1.29
Pretax Income	-170.44	-297.76	-297.84	-188.77	-149.34	24.93
Net Income	-220.77	-285.42	-318.76	-209.36	-149.34	24.93
Net Income to Common	-220.77	-285.42	-318.76	-209.36	-149.34	24.93
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	88	87	86	70	61	52
Shares Outstanding (Diluted)	88	87	86	70	61	54
Shares Change	2.18%	1.17%	21.67%	15.82%	13.31%	29.81%
EPS (Basic)	-2.51	-3.29	-3.72	-2.98	-2.46	0.48
EPS (Diluted)	-2.51	-3.29	-3.72	-2.98	-2.46	0.46
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-220.83	-323.17	-274.9	-160.6	-133.68	29
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-2.51	-3.73	-3.21	-2.28	-2.20	0.54
Gross Margin	95.78%	95.96%	96.51%	-	-	100.00%
Operating Margin	-76.98%	-158.45%	-1434.43%	-	-	18.77%
Profit Margin	-87.52%	-165.60%	-1346.11%	-	-	17.84%
FCF Margin	-87.54%	-187.50%	-1160.91%	-	-	20.76%
EBITDA	-194.16	-273.08	-339.66	-229.94	-151.72	26.26
EBITDA Margin	-76.97%	-158.44%	-1434.39%	-	-	18.80%
EBIT	-194.17	-273.08	-339.67	-229.95	-151.76	26.22
EBIT Margin	-76.98%	-158.45%	-1434.43%	-	-	18.77%

SEC Filings: 10-K · 10-Q